Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The Accelerated Cure Project and the Italian Multiple Sclerosis Society Collaborate to Advance Patient-Reported Outcomes in MS Research, Patient Care and Product Development

This project will explore standardization of PRO measures between "patient-powered" research initiatives and will enable improved health, healthcare and quality of life for people affected by MS.


News provided by

Accelerated Cure Project for Multiple Sclerosis

May 30, 2018, 08:30 ET

Share this article

Share toX

Share this article

Share toX

WALTHAM, Mass., May 30, 2018 /PRNewswire-USNewswire/ -- The iConquerMS™ People-Powered Research Network, managed by Accelerated Cure Project, and the Italian MS Society PROMOPRO-MS database have announced a collaboration on a project to explore the feasibility of standardizing and harmonizing patient-reported outcome (PRO) measures between the two initiatives.  Both organizations have substantial experience in collecting PROs for MS research and healthcare.

The overall goal of the collaboration is to improve the health, healthcare and quality of life of people affected by MS by capturing the entire experience of symptoms, abilities and quality of life in a standardized form.  There is a rapidly growing interest in shared treatment decision-making in MS based on PROs.  Incorporating the "patient voice" in research, drug development, drug approvals, and healthcare technology assessments, requires the standardization and harmonization of PRO measures for MS in culturally appropriate ways, across different countries.

Despite the progress that has been made in MS treatment research over the past 25 years, people with MS and their physicians are faced with substantial challenges in treatment decision-making.  Benefit-risk profiles of the available disease modifying therapeutics (DMTs) are complex and major evidence gaps still remain, particularly on the effects of treatment on the symptoms, disabilities and quality of life areas that matter most to people with MS.

"As a person living with MS who experiences many debilitating symptoms that are not routineIy collected in a standardized form at or between clinic visits, nor in clinical trials for new MS medicines, I am excited by the prospect that this collaboration will bring the outcomes that matter most to people affected by MS into every aspect of my care and in research to improve treatments," said Laura Kolaczkowski, Co-Principal Investigator of the iConquerMS™ People-Powered Research Network.

"This collaboration aims to establish a system and tools for the collection, presentation and interpretation of patient-reported health information and outcomes for MS, in culturally-appropriate ways, across countries for use in research and in shared healthcare decision-making," commented Giampaolo Brichetto, Coordinator of Research in Rehabilitation and Principal Investigator of the PROMOPRO-MS database at the Italian Multiple Sclerosis Society Foundation.

There are a very large number of PRO survey instruments for MS, and their ad hoc use in addressing research questions are confounding factors for translating the results of research studies involving PROs into improvements in the health, healthcare and quality of life for people with MS.  There have been a number of publications on the relationships amongst the diverse PRO survey instruments.  A clear need has been identified for more research on the systems and tools used for MS PRO collection, and the presentation and interpretation of PROs for use in healthcare decision-making.

"The results of the collaboration will provide important insights to advise Regulatory Agencies and the other stakeholders on an appropriate patient-reported outcome core data set to be collected and included in MS registries and beyond," said Paola Zaratin, Italian MS Society Scientific Director.

"Standardizing, and harmonizing the use of, a core set of PRO measures for MS across countries and cultures will ultimately enable patients, physicians, regulatory agencies, and other stakeholders to 'speak the same language' worldwide about the entire experience of MS beyond standard clinical assessments, and for that information to be included along with clinical assessments in electronic health records and registries, in research studies, and as outcome measures in product development clinical trials," explained Robert McBurney, Co-Principal Investigator of the iConquerMS™ People-Powered Research Network and CEO of Accelerated Cure Project.

About the iConquerMS™ People-Powered Research Network
iConquerMS™ (www.iConquerMS.org) is a research initiative by and for individuals affected by MS who contribute their ideas and their health data.  iConquerMS™ was established in 2014 by the Accelerated Cure Project for MS, a non-profit organization with proven experience sharing resources with MS researchers worldwide, in partnership with Feinstein Kean Healthcare (www.fkhealth.com) and Arizona State University.  To date, funding for iConquerMS™ has been largely provided by the Patient-Centered Outcomes Research Institute (PCORI) (www.PCORI.org) and the initiative is part of PCORnet (www.pcornet.org), the national patient-centred clinical research network.  Almost 5,000 individuals living with MS are currently registered as iConquerMS™ research participants, constituting a large and growing cohort for data-driven research into topics of interest for people affected MS.  iConquerMS™ is available for and enthusiastically open to research collaborations with U.S. and international academic, government and industry organizations.

About Accelerated Cure Project
Accelerated Cure Project (www.acceleratedcure.org) is a patient-founded non-profit organization dedicated to accelerating research efforts to improve diagnoses, optimize treatment outcomes, and develop cures for MS.  The organization promotes scientific collaboration and accelerates research by rapidly and cost-effectively providing researchers with resources they need to explore novel research ideas that can lead to better outcomes for people living with MS.  The major programs of Accelerated Cure Project are the ACP Repository and the iConquerMS™ People-Powered Research Network.

About the Italian MS Society
The Italian Multiple Sclerosis Society - AISM, through its Foundation - FISM (Italian Multiple Sclerosis Foundation), is the leading funding agency of MS research in Italy and the third leading funding agency worldwide of research to better understand the causes of illness, to improve the quality of life of people with MS (PwMS), and to provide better treatment towards a definitive cure for a MS.  The overall goal of the Italian MS Society is to make the bridge walkable between PwMS and healthcare government agencies and thus support PwMS in making decisions for their treatments and quality of life.  The Italian MS Society performs research in the area of PRO through the PROMOPRO-MS initiative that has been funded since 2013.

Accelerated Cure Project and iConquerMS™ Contact for Media:
Kristin Mulligan
Feinstein Kean Healthcare
+1-617-761-6790

Accelerated Cure Project and iConquerMS™ Contact for All Other Inquiries:
Sara Loud
Accelerated Cure Project, Inc.
+1-617-817-5294
+1-781-487-0032

Italian MS Society Contact for Media:
Roberta Guglielmino
Italian MS Society
+39-010-2713407

Italian MS Society Contact for All Other Inquiries:
Giampaolo Brichetto
Italian MS Society
+39-347-8029973

SOURCE Accelerated Cure Project for Multiple Sclerosis

Related Links

http://www.acceleratedcure.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Accelerated Cure Project Launches AI Caregiving Expert: A 24/7 Resource for Care Partners of People with MS

Accelerated Cure Project Launches AI Caregiving Expert: A 24/7 Resource for Care Partners of People with MS

People who are caring for loved ones with multiple sclerosis (MS) now have an additional resource to answer their questions at any time. In addition...

MS Care Partner Connection: A One-Stop Shop for Caregivers in Need of Support and Information

MS Care Partner Connection: A One-Stop Shop for Caregivers in Need of Support and Information

An estimated 1 million people in the U.S. have been diagnosed with multiple sclerosis (MS)1 and it is likely between 30 and 50 percent receive some...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Publishing & Information Services

Publishing & Information Services

New Products & Services

New Products & Services

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.